Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. Alba C, Malhotra S, Horsfall S, Barnhart ME, et al. PLoS One 2025;20:e0318940.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alba C, Malhotra S, Horsfall S, Barnhart ME, et al. Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. PLoS One 2025;20:e0318940.
PMID: 40106399